“Now, just to put this in some context ... Moderna, as a company, for over a decade tried to bring a singular product to market but was never able to do it one time, until the COVID vaccine,” he explains.
“So somehow, somehow they were unable to harness this mRNA technology for over a decade to successfully bring one, not even a single product to market one time, and yet, under the gun, the pressure of a once-in-a-century pandemic, they pulled it off,” he continues.
No comments:
Post a Comment